Video
Diffuse Large B-Cell Lymphoma Highlights From ASH 2023
- Author:
- Nicholas R. Burwick, MD
Publish date: January 3, 2024
DLBCL highlights from ASH 2023 include chemotherapy-free regimens in frontline and recurrent settings as well as data on racial disparities in...
Article
Chronic Lymphocytic Leukemia Highlights From ASH 2022
- Author:
- Nicholas R. Burwick, MD
Publish date: January 11, 2023
CLL treatments from ASH 2022 include pirtobrutinib in pretreated patients, zanubrutinib in relapsed/refractory disease, and frontline ibrutinib +...